Breaking Down Mental Health (Season 2) - Episode 5 Treatment Resistant Depression

Featured guest: Daniel Maixner, M.D.

Objectives

• Define treatment resistant depression.
• Define electroconvulsive therapy, and its risks, benefits, and rationale for treatment modality.
• Define transcranial magnetic stimulation, and its risks, benefits, and rationale for treatment modality.
• Define ketamine therapy for treatment resistant depression, and its risks, benefits, and rationale for a treatment modality.

Resources

• Systematic review: electroconvulsive therapy for treatment-resistant mood disorders in children and adolescents (European Child & Adolescent Psychiatry)
• Transcranial magnetic stimulation for adolescent depression (Child & Adolescent Psychiatry Clinics)
• Efficacy of intravenous ketamine in adolescent treatment-resistant depression: a randomized midazolam-controlled trial (American Journal of Psychiatry) 
• Annual research review: defining and treating pediatric treatment-resistant depression (Journal of Child Psychology Psychiatry)

Credits available: 0.5